Kamiya Biomedical Co has introduced a new K-ASSAY® fructosamine reagent for the quantitative determination of human fructosamine in serum. According to the American Diabetes Association, measurement of fructosamine is particularly useful when rapid changes in diabetes treatment occur. Evaluation of diet or medication effectiveness can be made in just a couple of weeks, or during diabetic pregnancy. The fructosamine reagent was developed for use on most chemistry analyzers, including the Roche/Hitachi, Olympus AU series, Beckman Synchron, Abbott Aeroset, and others. No sample preparation is necessary. Linear range is 1.0 to 10.0 mmol/L. A variety of sizes are available to match different testing volumes.

Kamiya Biomedical Co
(206) 575-8068; www.kamiyabiomedical.com